Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent Cough in IPF”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Ended earlyNCT03864328
What this trial is testing

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Who this might be right for
Persistent Cough in IPFChronic CoughIPF
Respivant Sciences GmbH 108
Testing effectiveness (Phase 2)Study completedNCT02502097
What this trial is testing

Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)

Who this might be right for
Idiopathic Pulmonary FibrosisCough
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 51

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation